Aggression

Psychiatry of Intellectual Disability: A Practical Manual

Volumn , Issue , 2012, Pages 210-249

  Gentile, Julie P ^a   Gillig, Paulette Marie ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Aggression, multi determined, requiring careful diagnosis; Aggression, to be understood within its situational context; Behavioral problems, and mental illness co occurring; Behavioral symptoms, in individuals with ID; Diagnostic criteria, for problem and self injurious behavior; ECT for catatonic regression, self injurious behavior and aggression; Individuals with ID, vulnerability to anxiety and mood disorders; Mental health appointments, aggression in various forms; Psychiatric, behavioral interventions, rarely being the answer; Syndromes associated with SIB

Indexed keywords

EID: 84884162492     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119945925.ch11     Document Type: Chapter

References (81)

1. Allen, D.G., Lowe, K., Moore, K.&Brophy, S. (2007). Predictors, costs and characteristics of out of area placement for people with intellectual disability and challenging behaviour. Journal of Intellectual Disability Research 51(6), 409-416
2. Aman, M.G., Crismon, M.L., Frances, A., King, B.H. & Rojahn, J. (eds.) (2004). Treatment of psychiatric and behavior problems in individuals with mental retardation: an update of the expert consensus guidelines for mental retardation and developmental disability populations Postgraduate Institute for Medicine, Englewood, CO
3. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). APA, Washington, DC
4. Antonacci, D.J., Manuel, C. & Davis, E. (2008). Diagnosis and treatment of aggression in individuals with developmental disabilities. Psychiatric Quarterly 79, 225-247
5. Aziz, M., Maixner, D.F., DeQuardo, J., Aldridge, A. & Tandon, R. (2001). ECT and mental retardation: A review and case reports. Journal of ECT 17(2), 149-152
6. Baumeister, A.A., Sevin, J.A. & King, B.H. (1998). Neuroleptics. In: Reiss, S., Aman, M.G (eds.) The International Consensus Handbook. pp. 133-150. Ohio State University Press, Columbus, OH
7. Campbell,W.H.&Rohrbaugh, R.M. (2006). The Biopsychosocial Formulation Manual: AGuide for Mental Health Professionals. Routledge, New York
8. Carvill, S. & Marston, G. (2002). People with intellectual disability, sensory impairments and behavior disorder; a case series. Journal of Intellectual Disability Research 46(3), 264-272
9. Charlot, L. & Shedlack, K. (2002). Masquerade: Uncovering and treating the many causes of aggression in individuals with developmental disabilities. NADD Bulletin 5, 59-64
10. Clark, D.J., Kelley, S., Thinn, K. & Corbett, J.A. (1990). Psychotropic drugs and mental retardation: I. Disabilities and the prescription of drugs for behavior and for epilepsy in 3 residential settings. Journal of Mental Deficiency Research 28, 229-233
11. Collacott,R.A.,Cooper,S-A.,Branford,D.&McGrother,C. (1998).Epidemiologyofself-injurious behaviour in adults with learning disabilities. British Journal of Psychiatry 173, 428-432
12. Connor, D.F., Glatt, S.J., Lopez, I.D., Jackson, D. & Melloni, R.H., Jr., (2002). Psychopharmacology and aggression. I: a meta-analysis of stimulant effects on overt/covert aggressionrelated behaviors in ADHD. Journal of The American Academy Of Child and Adolescent Psychiatry 41, 263-261
13. Cooper, S-A., Smiley, E., Allan, L.M., Jackson, A., Finlayson, J., Mantry, D. & Morrison, J (2009). Adults with intellectual disabilities: prevalence, incidence and remission of selfinjurious behaviour, and related factors. Journal of Intellectual Disability Research Special Issue 53(3), 200-216
14. Davidson, P., Cain, N., Sloane-Reeves, J., Van Speybroech, A., Segal, J., Gutkin, J., et al. (1994) Characteristics of community-based individuals with mental retardation and aggressive behavioral disorders. American Journal of Mental Retardation 98, 704-716
15. Deb, S. & Fraser, W. (1994). The use of psychotropic medication in people with learning disability: Towards rational prescribing. Human Psychopharmacology 9, 259-272
16. Deb, S. & Unwin, G.L. (2007a) Guide to using psychotropic medication for the management of behaviour problems among adults with intellectual disability. Technical document, Section 3: Systematic reviews. University of Birmingham, Birmingham, UK. Available at www.ldmedication.bham.ac.uk
17. Deb, S. & Unwin, G. (2007b). Psychotropic medication for behaviour problems in people with intellectual disability: A review of current literature. Current Opinion in Psychiatry 20, 461-466
18. Deb, S., Thomas, M.&Bright, C. (2001). Mental disorder in adults with intellectual disability 2: The rate of behavior disorders among a community-based population aged between 16 and 64 years. Journal of Intellectual Disability Research 45(6), 506-514
19. Deb, S., Sohanpal, S.K., Soni, R. Unwin, G. & Lenôtre, L. (2007). The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disabilities. Journal of Intellectual Disability Research 51, 766-777
20. Deb, S., Chaplin, S., Sohanpal, G., Unwin, G. Soni, R.&LenÔtre, L. (2008). The effectiveness of mood stabilizers and antiepileptic medication for the management of behavior problems in adults with intellectual disability: a systematic review. Journal of Intellectual Disability Research 52, 107-113
21. Dhossche, D.M.&Rout, U. (2006). Are autistic and catatonic regression related?A fewworking hypotheses involving gaba, Purkinge cell survival, neurogenesis, and ECT. International Review of Neurobiology 72, 55-79
22. Dhossche, D.M.&Stanfill, S. (2004). Could ECT be effective in autism? Medical Hypotheses 63 (3), 371-376
23. Didden, R., Korzilius, H., van Aperlo, B., van Overloop, C. & de Vries, M. (2002). Sleep problems and daytime problem behaviours in children with intellectual disability. Journal of Intellectual Disability Research 46(7), 537-547
24. Dykens, E.M., Hodapp, R.M. & Finucane, B.M. (2000). Genetics and mental retardation syndromes: A new look at behavior and interventions. Paul HBrookes Publishing, Baltimore,MD
25. Einfeld, S.L. & Tonge, B.J. (1999). Observations on the use of the ICD-10 guide for the mental retardation. Journal of Intellectual Disability Research 45, 408-412
26. Emerson, E., Kiernan, C., Alborz, A., Reeves, D., Mason, H., Swarbrick, R., Mason, L. & Hatton, C. (2001a). Predicting the persistence of severe self-injurious behavior. Research in Developmental Disabilities 22, 67-75
27. Emerson, E., Kiernan, C., Alborz, A., Reeves, D., Mason, H., Swarbrick, R., Mason, L.&Hatton, C. (2001b). The prevalence of challenging behaviors: A total population study. Research in Developmental Disabilities 22, 77-93
28. Fletcher, R., Loschen, E., Stavrakaki, C. & First, M. (eds.) (2007). Diagnostic Manual - Intellectual Disability (DM-ID): ATextbook of Diagnosis of Mental Disorders in Persons with Intellectual Disability. NADD Press, Kingston, NY
29. Gagiano, C., Read, S., Thorpe, L., Eerdekens, M. & Van Hove, I. (2005). Short- and long-term efficacy and safety of risperidone in adults with disruptive behavior disorders. Psychopharmacology 179, 629-636
30. Gardner,W.I. (2002). Aggression and Other Disruptive Behavioral Challenges: Biomedical and Psychosocial Assessment and Treatment. NADD Press, Kingston, NY
31. Green,W.H. (2001). Child and adolescent clinical psychopharmacology. LippincottWilliams& Wilkins, Philadelphia
32. Guay, D.P. (2008). Inappropriate Sexual Behaviors in Cognitively Impaired Older Individuals American Journal of Geriatric Pharmacotherapy 6(5). 269-288
33. Guay, D.P. (2009). Drug Treatment of Paraphilic and Nonparaphilic Sexual Disorders. Clinical Therapeutics 31(1), 1-31
34. Habler, F. & Reis, O. (2010). Pharmacotherapy of Disruptive Behavior in Mentally Retarded Subjects: A Review of the Current Literature. Developmental Disabilities Research Reviews 16, 265-272
35. Handen, B.L. & Gilchrist, R. (2006). Practitioner review: psychopharmacology in children and adolescent with mental retardation. Journal of Child Psychology and Psychiatry And Allied Disciplines 47, 871-882
36. Handen, B.L. & Hardan, A.Y. (2006). Open-label, prospective trial of olanzapine in adolescents with subaverage intelligence and disruptive behavior disorders. Journal of The American Academy Of Child and Adolescent Psychiatry 45, 928-935
37. Hardan, A. & Sahl, R. (1997). Psychopathology in children and adolescents with developmental disorders. Research in Developmental Disabilities 18, 369-382
38. Hillbrand, M. (1995). Aggression against self and aggression against others in violent psychiatric patients. Journal of Consulting and Clinical Psychology 63, 668-671
39. Hogue, T., Steptoe, L., Taylor, J., Lindsay,W., Mooney, P., Pinkney, L., Johnston, S., Smith, A.H W. & O'Brien, G. (2006). A comparison of offenders with intellectual disability across three levels of security. Criminal Behavior and Mental Health 16, 13-28
40. Hollander, E., Wasserman, S., Swanson, E.N., Chaplin, W., Schapiro, M.L., Zagursky, K. & Novotny, S. (2006). A double-blind placebo-controlled pilot study of olanzapine in childhood/ adolescent pervasive developmental disorder. Journal of Child and Adolescent Psychopharmacology 16, 541-548
41. Hurley, A. (2005). Psychotherapy in an essential tool in the treatment of psychiatric disorders for people with mental retardation. Mental Retardation 43(6), 445-448
42. Hurley, A.D., Levitas, A., Lecavalier, L. & Pary, R.J. (2007). Assessment and diagnostic procedures. Special considerations for the metal health diagnostic interview for individuals with ID. In: Fletcher, R., Loschen, E., Stavrakaki, C. & First, M. (eds.) Diagnostic Manual-Intellectual Disability: A Clinical Guide for Diagnosis of Mental Disorders in Persons with Intellectual Disability. Chpt 2: 9-23. NADD Press/National Association for the Dually Diagnosed, Kingston, NY
43. Janowsky, D.S., Barnhill, L.J. & Davis, J.M. (2003a). Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: A retrospective, open-label, naturalistic trial. Journal of Clinical Psychiatry 64, 1258-1265
44. Janowsky, D.S., Kraus, J.E., Barnhill, L.J., Elamir, B. & Davis, J.M. (2003b). Effects of topiramate on aggressive, self-injurious, and disruptive/destructive behaviors in the intellectually disabled: An open-label retrospective study. Journal of Clinical Psychopharmacology 23(5), 500-504
45. Janowsky, D.S., Shetty, M. & Barnhill, L.J., (2004). Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial. International Journal of Neuropsychopharmacology 8, 37-48
46. Janowsky, D.S., Shetty, M., Barnhill, L.J., Elamir, B. & Davis, JM. (2005). Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviours in intellectually disabled adults: a retrospective, open label, naturalistic trial. International Journal of Neuropsychopharmacology 8, 37-48
47. Janowsky, D.S., Barnhill, L.J., Khalid, A.S. & Davis, J.M. (2006). Relapse of Aggressive and Disruptive Behavior in Mentally Retarded Adults Following Antipsychotic DrugWithdrawal Predicts Psychotropic Drug Use a Decade Later. Journal of Clinical Psychiatry 67, 1272-1277
48. Joyce, T., Ditchfield, H. & Harris, B. (2001). Challenging behavior in community services Journal of Intellectual Disability Research 45(2), 130-138
49. Kalachnik, J.E., Leventhal, B.B., James, D.H., Sovner, R., Kastner, T.A.,Walsh, K.,Weisblatt, S A.,&Klitzke, M.G. (1998). Guidelines for the use of psychotropic medication. In: Reiss, S.& Aman, M.G. (eds.) Psychotropic Medications and Developmental Disabilities: The International Consensus Handbook, pp. 45-72. The Ohio State Nisonger Center, Columbus, OH
50. Kalachnik, J.E., Hanzel, T.E., Sevenich, R. & Harder, Sr., (2002). Benzodiazepine behavioral side effects: Review and implications for individuals with mental retardation. American Journal on Mental Retardation 107(5), 376-410
51. Kane, J.M., Leucht, S., Capenter, D. & Docherty, J.P. (2003). The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Journal of Clinical Psychiatry 64 (Suppl. 12), 1-100
52. King, B.H. (2002). Psychopharmacology in mental retardation. Current Opinion in Psychiatry 15(5), 497-502
53. King, B.H., DeAntonio, C., McCracken, J.T., Forness, S.R. & Ackerland, V. (1994). Psychiatric consultation in severe and profound mental retardation. American Journal of Psychiatry 151 (12), 1802-1808
54. La Malfa, G., Bertelli, M. & Conte, M. (2001). Fluvoxamine and aggression in mental retardation. Psychiatric Services 52(8), 1105
55. La Malfa, G., Lassi, S., Bertelli, M. & Castellani, A. (2006). Reviewing the use of antipsychotic drugs in people with intellectual disability. Human Psychopharmacology: Clinical and Experimental 21, 73-89
56. Larson, S.A., Lakin, K.C., Anderson, L., Lee, N.K., Jeoung Hak Lee, J.H.&Anderson, D. (2001) Prevalence of mental retardation and developmental disabilities: estimates from the 1994/ 1995 National Health Interview Survey. American Journal of Mental Retardation 106(3), 231-252
57. Ligas, A., Petrides, G., Istafanous, R. & Kellner, C.H. (2009). Successful electroconvulsive therapy in a patient with intellectual disability and bipolar disorder, with catatonic features misdiagnosed as encephalopathy. Journal of ECT 25(3), 202-204
58. Lowry, M.&Sovner, R. (1991). The functional existence of problem behavior: a key to effective treatment. The Habilitative Mental Health Care Newsletter 10, 59-63
59. Matson, J.L. & LoVullo, S.V. (2008). A Review of Behavioral Treatments for Selfinjurious Behaviors of Persons with Autism Spectrum Disorders. Behavior Modification 32, 61
60. Matson, J.L.&Minshawi, N.F. (2007). Functional assessment of challenging behavior: Toward a strategy for applied settings. Research in Developmental Disabilities 28, 353-361
61. McClintock, K., Hall, S.&Oliver, C. (2003). Risk markers associated with challenging behaviors in people with intellectual disabilities: A meta-analytic study. Journal of Intellectual Disability Research 47, 405-416
62. Nijman, H.&Palmstierna, T. (2002). Measuring aggression with the staff observation aggression scale-revised. Acta Psychiatrica Scandinavica. Supplementum 412, 101-102
63. Pary, R.J., Silka, V.R.&Blaha, S.J. (1995). Mental retardation. In: Thienhaus, O.J. (ed.) Manual of Clinical Hospital Psychiatry, pp. 287-309. American Psychiatric Press,Washington, DC
64. Radouco-Thomas, M., Bolduc, M., Brisson, A., Brassard, P., Fortier, L. & Thivierge, J. (2004) Pilot study on the use of psychotropic medication in persons with mental retardation. Progress in Neuro-Psychopharmacology and Biological Psychiatry 28, 879-883
65. Rojahn, J., Matson, J.L., Naglieri, J.A.&Mayville, E. (2004). Relationships between psychiatric conditions and behavior problems among adults with mental retardation. American Journal on Mental Retardation 109(1), 21-23
66. Ruedrich, S.L., Swales, T.P., Rossvanes, C., Diana, L., Arkadiev, V. & Lim, K. (2008). Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities. Journal of Intellectual Disability Research 52(2), 132-140
67. Royal College of Psychiatrists (2001). DC-LD (Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation). Gaskell, London
68. Rueve, M.&Welton, R. (2008). Violence in Mental Illness. Psychiatry (Edgemont), 5(5) 35-48
69. Ryan, R. (2003). Intensive Conference on Dual Diagnosis. The Community Circle, Denver, CO CME Event
70. Sajith, S.G., Margan, C. & Clarke, D. (2008). Pharmacological management of inappropriate sexual behaviours: a review of its evidence, rationale and scope in relation to men with intellectual disabilities. Journal of Intellectual Disability Research 52(12), 1078-1090
71. Santosh, P.J.&Baird, G. (1999). Psychopharmacotherapy in children and adults with intellectual disability. The Lancet 354(9174), 233-242
72. Sigafoos, J., Elkins, J.,Kerr, M.&Attwood, T. (1994).Asurvey of aggressive behaviour among a population of persons with intellectual disability in Queensland. Journal of Geriatric Psychiatry 38, 369-381
73. Silka, V.R. &Hauser, M.J. (1997). Psychiatric assessment of the person with mental retardation Psychiatric Annals 27(3), 162-169
74. Taylor, J.L. (2002). A Review of the assessment and treatment of anger and Aggression in offenders with intellectual disability. Journal of Intellectual Disability Research 46 (Supplement I) 57-73
75. Tenneij, N.H., Didden, R., Stolker, J.J.&Koot, H.M. (2009). Markers for aggression in inpatient treatment facilities for adults with mild to borderline intellectual disability. Research in Developmental Disabilities 30, 1248-1257
76. Tyrer, F., McGrother, C., Thorp, C., Donaldson, M., Bhaumik, S., Watson, J.M. & Hollin, C (2006). Physical aggression towards others in adults with learning disabilities: Prevalence and associated factors, Journal of Intellectual Disability Research 50, 295-304
77. Verhoeven,W.M.A. & Tuiner, S. (2001). Cyclothymia or unstable mood disorder? A systematic treatment evaluation with valproic acid. Journal of Applied Research in Intellectual Disabilities 14, 147-154
78. Volavka, J., Citrome, L. & Huertas D. (2006). Update on the biological treatment of aggression A Review. Actas Espanolas de Psiquiatria 34(2), 123-135
79. Wachtel, L.E., Contrucci-Kuhn, S.A., Griffin, M., Thompson, A., Dhossche, D.M. & Reti, I.M (2009). ECT for self-injury in an autistic boy. European Child and Adolescent Psychiatry 18 (7), 458-63
80. Wachtel, L.E., Griffin, M. & Reti, I.M. (2010). Electroconvulsive therapy in a man with autism experiencing severe depression, catatonia, and self-injury. Journal of ECT 26(1): 70-3
81. World Psychiatry Association (2010). Clinical Bulletin of the Developmental Disabilities Division. International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities